GlassScriptPhysician profile
Evan S Jacobs
NPI 1215179882
$5,592.42
in general payments reported to CMS, 2019-2025
19 companies · $736 in 2025
The $736 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,359 · 2020: $422 · 2021: $458 · 2022: $632 · 2023: $825 · 2024: $1,159 · 2025: $736.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,720.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,720.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,322.36 | 2022-2025 | Cobalt Dr Mri Surescan, Micra, Azure Xt Dr Mri Surescan |
| Abbott Laboratories | $1,259.68 | 2019-2025 | Gallant, Assurity, Aveir |
| Novartis Pharmaceuticals Corporation | $710.16 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $411.55 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $328.45 | 2020-2025 | Jardiance |
| Medtronic Vascular, INC. | $278.32 | 2019 | |
| Boston Scientific Corporation | $222.27 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $175.65 | 2023-2025 | Camzyos, Eliquis |
| Cvrx, INC. | $158.76 | 2023 | Barostim Neo System |
| Amarin Pharma, INC. | $146.20 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $139.64 | 2019-2021 | |
| Pfizer INC. | $112.35 | 2019-2024 | |
| Ge Healthcare | $107.34 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $79.56 | 2022 | |
| Amgen INC. | $62.65 | 2019-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agepha Pharma Fz LLC | $24.78 | 2024 | Lodoco |
| Bayer Healthcare Pharmaceuticals INC. | $20.25 | 2023 | |
| Janssen Scientific Affairs, LLC | $20.00 | 2023 | Xarelto |
| Regeneron Healthcare Solutions, INC. | $12.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Jacobs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.